Kardiovaszkuláris hatóanyagok kutatása a Gyógyszerkutató Intézetben

Translated title of the contribution: Cardiovascular research at the Institute of Drug Research

Research output: Contribution to journalArticle

Abstract

The most significant achievements in the cardiovascular research areas have been reviewed. Among the β-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, β-adrenoceptor blocker).

Original languageHungarian
Pages (from-to)67-72
Number of pages6
JournalActa Pharmaceutica Hungarica
Volume71
Issue number1
Publication statusPublished - 2001

Fingerprint

Adrenergic Receptors
Research
Pharmaceutical Preparations
Antihypertensive Agents
tobanum

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Kardiovaszkuláris hatóanyagok kutatása a Gyógyszerkutató Intézetben. / Mátyus, P.

In: Acta Pharmaceutica Hungarica, Vol. 71, No. 1, 2001, p. 67-72.

Research output: Contribution to journalArticle

@article{482c6a8f5ae645ed8bf76953d938078c,
title = "Kardiovaszkul{\'a}ris hat{\'o}anyagok kutat{\'a}sa a Gy{\'o}gyszerkutat{\'o} Int{\'e}zetben",
abstract = "The most significant achievements in the cardiovascular research areas have been reviewed. Among the β-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, β-adrenoceptor blocker).",
author = "P. M{\'a}tyus",
year = "2001",
language = "Hungarian",
volume = "71",
pages = "67--72",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "1",

}

TY - JOUR

T1 - Kardiovaszkuláris hatóanyagok kutatása a Gyógyszerkutató Intézetben

AU - Mátyus, P.

PY - 2001

Y1 - 2001

N2 - The most significant achievements in the cardiovascular research areas have been reviewed. Among the β-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, β-adrenoceptor blocker).

AB - The most significant achievements in the cardiovascular research areas have been reviewed. Among the β-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, β-adrenoceptor blocker).

UR - http://www.scopus.com/inward/record.url?scp=0034945430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034945430&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 67

EP - 72

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 1

ER -